Back to Market Feed

Product Information

MULTAQ 400 MG TABLET is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $13.1875 per EA under NDC 00024414260. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jul 1, 2009.

MULTAQ 400 MG TABLET

Dronedarone
$13.1875per EA

Strength

400 mg/1

NDC

00024414260

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DRONEDARONE

Approval Type

New Drug (NDA)

FDA Application

NDA022425

FDA Approved

7/1/2009

On Market Since

7/1/2009

Pharmacological Classes

Antiarrhythmic
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for MULTAQ 400 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 137.0%. The table below summarizes its recorded NADAC range and movement.

Current price$13.1875 per EA
All-time high$13.1956 (Jun 10, 2026)
All-time low$5.5634 (Nov 28, 2013)
52-week high$13.1956
52-week low$12.9304
Median price$10.5125
Average price$10.3758
Largest weekly change+12.9% (Sep 17, 2014)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

+2.0%

3Y

+8.7%

5Y

+19.5%

All

+137.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dronedarone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

XYLOCAINE 2%-EPI 1:100,000
Brand
63323048327•Fresenius Kabi USA, LLC
$0.2655
per ML
XYLOCAINE 1%-EPI 1:100,000
Brand
63323048226•Fresenius Kabi USA, LLC
$0.2721
per ML
XYLOCAINE 1%-EPI 1:100,000
Brand
63323048227•Fresenius Kabi USA, LLC
$0.2721
per ML
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2069
per ML
SOTYLIZE 5 MG/ML ORAL SOLUTION
Brand
24338053025•Azurity Pharmaceuticals Inc.
$2.3174
per ML
SOTYLIZE 5 MG/ML ORAL SOLUTION
Brand
24338053048•Azurity Pharmaceuticals Inc.
$2.3245
per ML
ZONISADE 100 MG/5 ML ORAL SUSP
Brand
52652800101•Azurity Pharmaceuticals Inc.
$2.7505
per ML
NEORAL 25 MG GELATIN CAPSULE
Brand
00078024615•Novartis Pharmaceuticals Corporation
$2.9457
per EA
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
NORPACE CR 100 MG CAPSULE
Brand
00025273231•Pfizer Inc.
$4.1412
per EA

Frequently asked questions

What is the NADAC price of MULTAQ 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MULTAQ 400 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $13.1875 per EA (NDC 00024414260), effective Aug 19, 2026.

How has the price of MULTAQ 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for MULTAQ 400 MG TABLET has risen 137.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MULTAQ 400 MG TABLET?

Since Nov 28, 2013, the NADAC for MULTAQ 400 MG TABLET has ranged from a low of $5.5634 (Nov 28, 2013) to a high of $13.1956 (Jun 10, 2026), with a median of $10.5125 per EA.

Are there cheaper alternatives to MULTAQ 400 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of MULTAQ 400 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MULTAQ 400 MG TABLET?

MULTAQ 400 MG TABLET (NDC 00024414260) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.